scholarly journals Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil

2010 ◽  
Vol 105 (3) ◽  
pp. 299-303 ◽  
Author(s):  
Maria Betânia S Silva ◽  
Tarcísio M Andrade ◽  
Luciano K Silva ◽  
Itatiana F Rodart ◽  
Gisele B Lopes ◽  
...  
1994 ◽  
Vol 70 (5) ◽  
pp. 321-324 ◽  
Author(s):  
I van Beek ◽  
R Buckley ◽  
M Stewart ◽  
M MacDonald ◽  
J Kaldor

2011 ◽  
Vol 55 (1) ◽  
pp. 76-85 ◽  
Author(s):  
Jason Grebely ◽  
Gail V. Matthews ◽  
Margaret Hellard ◽  
David Shaw ◽  
Ingrid van Beek ◽  
...  

2005 ◽  
Vol 5 (2) ◽  
pp. 131-139 ◽  
Author(s):  
Oliver G. Pybus ◽  
Alexandra Cochrane ◽  
Edward C. Holmes ◽  
Peter Simmonds

2007 ◽  
Vol 18 (5) ◽  
pp. 359-363 ◽  
Author(s):  
Saman Zamani ◽  
Seiichi Ichikawa ◽  
Bijan Nassirimanesh ◽  
Mohsen Vazirian ◽  
Kazuko Ichikawa ◽  
...  

Addiction ◽  
1997 ◽  
Vol 92 (8) ◽  
pp. 999-1005 ◽  
Author(s):  
NICK CROFTS ◽  
LUCIANO NIGRO ◽  
KIMBERLEY OMAN ◽  
ELAINE STEVENSON ◽  
JOHN SHERMAN

2011 ◽  
Vol 83 (9) ◽  
pp. 1565-1570 ◽  
Author(s):  
Massimo Ciccozzi ◽  
Gianni Zehender ◽  
Valeria Cento ◽  
Alessandra Lo Presti ◽  
Pavel Teoharov ◽  
...  

2006 ◽  
Vol 135 (3) ◽  
pp. 433-442 ◽  
Author(s):  
K. M. ROY ◽  
S. J. HUTCHINSON ◽  
S. WADD ◽  
A. TAYLOR ◽  
S. O. CAMERON ◽  
...  

It is estimated that of 50000 persons in Scotland (1% of the county's population), infected with the hepatitis C virus (HCV), around 90% injected drugs. This paper reviews data on the prevalence and incidence of HCV, and the methods used to generate such information, among injecting drug users (IDUs), in Scotland. The prevalence estimate for HCV among IDUs in Scotland as a whole (44% in 2000), is comparable with those observed in many European countries. Incidence rates ranged from 11·9 to 28·4/100 person-years. The data have shaped policy to prevent infection among IDUs and have informed predictions of the number of HCV-infected IDUs who will likely progress to, and require treatment and care for, severe HCV-related liver disease. Although harm reduction interventions, in particular needle and syringe exchanges and methadone maintenance therapy, reduced the transmission of HCV among IDUs during the early to mid-1990s, incidence in many parts of the country remains high. The prevention of HCV among IDUs continues to be one of Scotland's major public health challenges.


Sign in / Sign up

Export Citation Format

Share Document